ASMB: Assembly Biosciences, Inc. Stock

by  •  • Comments Off on ASMB: Assembly Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 68.37
Enterprise Value ($M) 48.53
Book Value ($M) 41.10
Book Value / Share 7.50
Price / Book 1.66
NCAV ($M) 38.06
NCAV / Share 6.94
Price / NCAV 1.80

Profitability (mra)
Return on Invested Capital (ROIC) -1.41
Return on Assets (ROA) -0.74
Return on Equity (ROE) -0.87

Liquidity (mrq)
Quick Ratio 3.41
Current Ratio 3.41

Balance Sheet (mrq) ($M)
Current Assets 133.79
Assets 136.82
Liabilities 95.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.16
Operating Income -64.65
Net Income -61.23
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 22.74
Cash from Investing -69.14
Cash from Financing 13.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-22 13D/A Schornstein Alexander 11.51 5.58
10-25 13D Gilead Sciences Inc 19.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 2,218 12,003 18.48
2024-04-30 1,512 3,338 45.30
2024-04-29 2,366 3,648 64.86
2024-04-26 520 10,383 5.01

(click for more detail)

Similar Companies
ARQT – Arcutis Biotherapeutics, Inc. ARVN – Arvinas, Inc.
ARWR – Arrowhead Pharmaceuticals, Inc. ATHA – Athira Pharma, Inc.
ATRA – Atara Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io